Trial intelligence / Profile preview

Dexmedetomidine for Recovery After VATS

NCT02537249Completed

Sponsor
Yonsei University
Start
Aug 2015
Primary completion
Nov 2015
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in postoperative pain, sponsored by Yonsei University. Primary endpoint: Quality of Recovery-40 at 24 hours. Started Aug 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02537249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02537249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call